SuperworthContext Therapeutics shares outstanding CNTX
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 95.2M
- On a year earlier
- −0.0%
- fewer shares
Context Therapeutics had 95.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 95.2M | +16% |
| FY2024 | 81.8M | +412% |
| FY2023 | 16M | +0% |
| FY2022 | 16M | +4482% |
| FY2020 | 348.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 95.2M | −0% | |
| Q1 FY26 | 95.2M | −0% | |
| Q4 FY25 | 95.2M | +16% | |
| Q3 FY25 | 95.2M | +18% | |
| Q2 FY25 | 95.2M | +73% | |
| Q1 FY25 | 95.2M | +496% | |
| Q4 FY24 | 81.8M | +412% | |
| Q3 FY24 | 80.5M | +404% | |
| Q2 FY24 | 55M | +244% | |
| Q1 FY24 | 16M | +0% | |
| Q4 FY23 | 16M | +0% | |
| Q3 FY23 | 16M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Context Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.